RNS Number : 0194V
Stenprop Limited
18 July 2018
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
18 July 2018
DEALING IN SECURITIES BY A DIRECTOR OF THE COMPANY
Shareholders are advised of the following information relating to the dealing in securities by a director of Stenprop:
Name of director: | Philip John Holland, non-executive director |
Transaction date: | 17 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 24 999 |
Price per security: | £1.20 |
Total value of transaction: | £29 998.80 |
Nature of transaction: | On-market purchase of ordinary shares on the London Stock Exchange through the director's self-invested personal pension |
Nature and extent of director's interest: | Indirect beneficial |
Clearance to deal received in accordance with the Listings Requirements of the JSE Limited: | Yes |
For further information:
Stenprop Limited 44(0)20 7079 6600
Paul Arenson
Patsy Watson
Julian Carey
Numis Securities Limited (Financial Adviser) 44(0)20 7260 1000
Hugh Jonathan
Vicki Paine
Tavistock (PR Adviser) 44(0)20 7920 3150
James Whitmore
James Verstringhe
Kirsty Allan
Instinctif Partners (SA Investor Relations and PR Adviser) 27 (0)11 447 3030
Keagile Makgoba
Java Capital Trustees and Sponsors Proprietary Limited 27 (0)11 722 3050
(JSE sponsor)
About Stenprop:
Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.